There is still no medical cure for inflammatory bowel diseases (IBD) and the clinical management is challenging. In particular, differentiating between Crohn’s disease (CD) and ulcerative colitis (UC) and predicting the clinical course or the response to therapy is difficult. In this study, we aim to characterize tissue samples from IBD and control patients with […]
Lymphatic vessels are specialized vessels that transport immune cells and fat out of the gut to maintain health. Surgeons treating Crohn’s disease decades ago argued that impaired lymphatic flow may be a key problem in the disease. However, only recently have tools emerged to study lymphatic vessels in detail. We have data that lymph transport […]
Intestinal Bowel Diseases (IBD) affect millions of lives worldwide. However, therapeutic options for IBD treatment are limited. In this proposal, building upon our previous findings, we propose to examine an important protein called ARTS, which has never-before been studied in connection to IBD. We have found that ARTS is able to coordinate the cellular suicide […]
More than half of Crohn’s disease (CD) patients develop excessive scar tissue leading to intestinal blockage, ultimately requiring surgery with removal of parts of the bowel. This process can repeat itself, often resulting in multiple surgeries. There are many therapies that treat gut inflammation, but even when gut inflammation is controlled excessive scar tissue still […]
There is still no medical cure for inflammatory bowel diseases (IBD) and the clinical management is challenging. In particular, differentiating between Crohn’s disease (CD) and ulcerative colitis (UC) and predicting the clinical course or the response to therapy is difficult. In this study, we aim to characterize tissue samples from IBD and control patients with […]
Precise manipulation of diet and gut microbiota is a novel and non-invasive therapy for IBD which is of great interest to patients. Enteral nutrition provides a clear example of a dietary intervention improving clinical outcomes such as mucosal healing. However, previous studies in IBD have altered several different dietary components at once making it challenging […]
The gut microbiota is believed to play a critical role in inflammation in Crohn’s disease (CD). Adherent–invasive Escherichia coli (AIEC) often colonize the intestinal mucosa of CD patients. AIEC colonization may promote intestinal inflammation in CD patients. We have found that AIEC prefers to use the amino acid L-serine for growth in the inflamed gut. […]
Lymphatic vessels are specialized vessels that transport immune cells and fat out of the gut to maintain health. Surgeons treating Crohn’s disease decades ago argued that impaired lymphatic flow may be a key problem in the disease. However, only recently have tools emerged to study lymphatic vessels in detail. We have data that lymph transport […]
IBD is a complex disorder that results from a dysregulated immune response in the gut. Current and emerging therapy for IBD treatment is mainly focused on regulation of the immune response. Exosomes are nanovesicle packing different molecules that transfer their cargo to recipient cells. Mammalian milk contains high concentrations of exosomes (MDE) carrying immune-related molecules. […]
